Suppr超能文献

Erratum: Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis [Corrigendum].

出版信息

Onco Targets Ther. 2018 Jul 31;11:4449. doi: 10.2147/OTT.S179985. eCollection 2018.

Abstract

[This corrects the article on p. 2647 in vol. 11, PMID: 29780257.].

摘要

相似文献

2
Corrigendum.
Paediatr Child Health. 2015 Nov-Dec;20(8):466-7. doi: 10.1093/pch/20.8.466.
3
ERRATUM.
Int J Bioprint. 2020 Sep 17;6(4):309. doi: 10.18063/ijb.v6i4.309. eCollection 2020.
5
Erratum: Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum].
Breast Cancer (Dove Med Press). 2018 Mar 16;10:51. doi: 10.2147/BCTT.S166117. eCollection 2018.
6
Erratum: Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum].
Int J Womens Health. 2015 Apr 16;7:403. doi: 10.2147/IJWH.S85889. eCollection 2015.
7
Erratum: Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature [Corrigendum].
Onco Targets Ther. 2017 Mar 21;10:1707. doi: 10.2147/OTT.S135552. eCollection 2017.
10
Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis.
Onco Targets Ther. 2018 May 8;11:2647-2656. doi: 10.2147/OTT.S165681. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验